SLC3A2 and head and neck squamous cell carcinoma: Our previous study also showed that high expression of CD98hc and LAT1 are associated with poor prognoses in patients with HNSCC treated with primary radiochemotherapy (RCTx) or postoperative radiochemotherapy (PORT-C) (11, 43, 116).